HBIO Harvard Bioscience Inc.

NASDAQ
$8.42

Harvard Bioscience Inc. (HBIO) is confirmed to report earnings on November 10, 2026, before the market open.

Harvard Bioscience Reported Earnings
Tuesday, August 11, 2026 · 7:00 AM ET
Earnings Date
Nov 10
Tuesday · 7:30 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Harvard Bioscience Inc.

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of apparatus and scientific instruments, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories.

Sector

Technology

Industry

Scientific / Technical Instruments

Charts powered in part by Lightweight Charts™ by TradingView.